comparemela.com

Latest Breaking News On - Inovio pharmaceuticals stock down - Page 1 : comparemela.com

Inovio Pharmaceuticals (NASDAQ:INO) Releases Earnings Results, Misses Expectations By $0 02 EPS

Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) announced its earnings results on Wednesday. The biopharmaceutical company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02), RTT News reports. The company had revenue of $0.11 million for the quarter, compared to analyst estimates of $0.20 million. Inovio Pharmaceuticals had […]

Inovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Underperform at Bank of America

Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.